Vitality Watch

Dossier clinicaltrials observational 17-sep-2026
Human cohort, case-control, or epidemiological association

Risk Markers of Arterial Aging. The Paris Prospective Study III-2

Key claim: The Paris Prospective Study III-2 will reassess vascular aging and baroreflex sensitivity 12–16 years apart, identify their determinants, and quantify subsequent cardiovascular disease risk.

Abstract

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Why this matters

The Paris Prospective Study III-2 will reassess vascular aging and baroreflex sensitivity 12–16 years apart, identify their determinants, and quantify subsequent cardiovascular disease risk.

Source

Link

Briefing card

Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Stage: observational · clinicaltrials · 17-sep-2026

The Paris Prospective Study III-2 will reassess vascular aging and baroreflex sensitivity 12–16 years apart, identify their determinants, and quantify subsequent cardiovascular disease risk.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06079424

build build 880 · 2bcef25 · 2026-11-18